 |
|
|
|
|
|
|
Home |
Patients |
and Clinics |
Links |
Us |
Page |
Information |
|
|
|
|
|
|
|
Home |
Patients |
and Clinics |
Links |
Us |
Page |
Information |
|
 |
 |
|
|
Richard Kefford is Professor of Medicine at the University of Sydney (Western Clinical School), Chair of the Division of Medicine, Westmead Hospital, Sydney and Director of the Westmead Institute for Cancer Research at Westmead Millennium Institute. He graduated in medicine from the University of Sydney then trained in medical oncology at Royal Prince Alfred Hospital, and as a graduate student at the Ludwig Institute for Cancer Research, Sydney, where he gained a PhD in purine biochemistry. His post-doctoral period was spent with Nobel Laureate, Dr Cesar Milstein at the Laboratory of Molecular Biology, MRC Centre, Cambridge, UK on a Howard Florey Fellowship of the Royal Society of London. He founded the Department of Medical Oncology at Westmead Hospital in 1986 and continues clinical practice in the medical treatment of melanoma and breast cancer at Westmead Hospital, Westmead Private Hospital, the Mater Hospital North Sydney and the Hills Private Hospital, Sydney. He has conducted research into molecular genetics of melanoma continuously since 1985. His research group played a major role in the mapping of the melanoma susceptibility gene p16 and in characterising hereditary mutations in this gene, which predispose individuals to a very high risk of melanoma. Professor Kefford is Consultant Medical Oncologist to the Sydney Melanoma Unit and the NSW Breast Cancer Institute. He is a Member of the National Breast Cancer Centre (NBCC) Clinical Expert Advisory Panel, the WHO Melanoma Group, and founding member of the international Melanoma Genetics Consortium. He is a member of the Research Committee of the National Health and Medical Research Council and Chairs its Project Grants Committee. He is a member of the Medical Oncology Group (Australia), the American Society of Clinical Oncology, the American Association for Cancer Research and the Australian Medical Association. He has been Visitng Professor of the Cancer Society of New Zealand and an invited plenary speaker at the New Zealand Society of Oncology, the World Melanoma Conference, the World Congress of Dermatology, the American Society of Clinical Oncology Annual Meeting, the Lorne Cancer Conference and the Clinical Oncological Society of Australia Annual Meeting. He is the author of over 140 papers in the peer-reviewed medical literature. | Professor Kefford | Disclaimer | Dr Catriona McNeil | | Return Home | New Patients | Services and Clinics | Useful Links | Contact Us | Download Page | Cancer Information | |
||
 |
 |
